By comparison, 4 out of 10,000 people, or 0.04%, who were matched in the database based on their age, sex, ethnicity and other factors, but who were not taking a GLP-1 medication, developed the condition
Domenica M
Rare but serious risks can include gallstones, pancreatitis, and surgical complications related to delayed stomach emptying
Furthermore, it highlights the potential for similar medications to emerge, offering additional options for those who may not respond to Semaglutide
While some peptides like insulin and GLP-1 medications are proven medicines, many peptides promoted online are untested, unproven, and potentially dangerous substances not approved for human use